INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC FORM 49m ago
HOUSE PTR9m ago
SEC 13F9m ago
ROBINHOOD CHAIN9m ago

Most active filers · 30d

  1. 01Kurtz George0B / 238S · 10 late238 trades$60.26M
  2. 02SPSaba Capital Management, L.P.60B / 23S · 3 late83 trades$25.07M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 31S31 trades$5.54M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

21,218 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$184K
320 sh
Nov 5, 2026
Page 8 of 531
← PrevNext →
Nov 6, 2026
traded Nov 5, 2026
+1d
SEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$180K
320 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$139K
240 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$89K
156 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$215K
375 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$184K
320 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$127K
221 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
KT
Kelly Roland ThomasChief Legal Officer and GC
VELVelocity Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
3,200 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$135K
1,460 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$100K
167 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$119K
200 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$186K
320 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$166K
280 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$186K
320 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$71K
120 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$142K
237 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$70K
120 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$193K
330 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$183K
306 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$182K
310 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$95K
160 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

13
SF
Shimanovsky Boris F.EVP, Chief Technology Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$141K
30.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$93K
160 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

12
DB
Dempsey Tyler BGeneral Counsel
RPAYRepay Holdings Corp
Open-market sale · 10b5-1 plan
SELL$119K
25.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

12
TF
Tan FionaChief Technology Officer
WWayfair Inc.
Open-market sale · 10b5-1 plan
SELL$859K
7,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

12
JK
Johnson Sandra K.Director
RMRegional Management Corp.
Open-market sale · 10b5-1 plan
SELL$77K
2,009 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

12
BP
Buckley Sean PatrickSee Remarks
MGNIMAGNITE, INC.
Open-market sale · 10b5-1 plan
SELL$297K
11.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

11
ZM
Zerbe Robert L MdDirector
VCELVericel Corp
Open-market sale · 10b5-1 plan
SELL$28K
500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

11
MD
Mansueto Joseph DDirector, Executive Chairman, 10% Owner
MORNMorningstar, Inc.
Open-market sale · 10b5-1 plan
SELL$467K
1,896 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

11
MD
Mansueto Joseph DDirector, Executive Chairman, 10% Owner
MORNMorningstar, Inc.
Open-market sale · 10b5-1 plan
SELL$724K
2,932 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

11
MD
Mansueto Joseph DDirector, Executive Chairman, 10% Owner
MORNMorningstar, Inc.
Open-market sale · 10b5-1 plan
SELL$557K
2,248 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

11
PJ
Peters William JDirector, CFO, EVP & TREASURER
AMPHAmphastar Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$366K
12.6K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

11
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$600K
2,900 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

11
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$523K
2,502 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

11
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$794K
3,773 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

11
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$317K
1,500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

11
AR
Altschuler RandolphDirector
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$259K
2,358 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 8 – Sep 166 insiders$2.66M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K